Physician profile
Yohan Lee
NPI 1992013528
$5,407.08
in general payments reported to CMS, 2019-2025
17 companies · $2,132 in 2025
The $2,132 reported for 2025 was more than what 80% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $902 · 2020: $157 · 2021: $332 · 2022: $397 · 2023: $692 · 2024: $795 · 2025: $2,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,818 · Travel and Lodging: $676 · Consulting Fee: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,818.20 |
| Travel and Lodging | $676.11 |
| Consulting Fee | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,357.18 | 2019-2025 | General - Pain Management, Intracept, Superion Indirect Decompression System |
| Saluda Medical Americas, INC. | $1,222.29 | 2025 | Evoke |
| Scilex Pharmaceuticals INC. | $691.70 | 2019-2025 | Ztlido |
| Medtronic USA, INC. | $396.43 | 2019-2020 | |
| Relievant Medsystems, INC. | $347.74 | 2022-2023 | Intracept |
| Horizon Therapeutics Plc | $234.02 | 2019-2021 | |
| Abbvie INC. | $191.03 | 2022-2025 | |
| Medtronic, INC. | $189.80 | 2023-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $175.85 | 2024-2025 | |
| Nalu Medical, INC. | $142.33 | 2024-2025 | Nalu Neurostimulation System |
| Protega Pharmaceutials INC | $141.80 | 2025 | Roxybond |
| Si-Bone, INC. | $92.80 | 2020-2024 | |
| Nevro Corp. | $63.07 | 2020 | |
| Allergan, INC. | $52.79 | 2021-2022 | |
| Avanos Medical | $52.70 | 2025 | Standard Rf Disposables |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $31.99 | 2022 | |
| Forte Bio-Pharma LLC | $23.56 | 2023 | Prolate, Nalocet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yohan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.